Acquired Brain InjuryNEURO-TEANCT07881042
Transition From Pediatric to Adult Care in Young Adults With Acquired Brain Injury
An observational study of Acquired Brain Injury, run by Hopitaux de Saint-Maurice at 1 site in France.
Trial summary
This retrospective, single-center observational study evaluates young adults with acquired brain injury who attended a joint pediatric-adult Physical and Rehabilitation Medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 2022 and January 2026. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acquired Brain Injury
- How many people
- 72 participants
- Where
- 1 siteFrance
- Study dates
- 1 Jul 2026to Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population consists of young adults with acquired brain injury occurring during childhood or adolescence who received care within the joint pediatric-adult Physical and Rehabilitation Medicine transition program at Hôpitaux Paris Est Val-de-Marne. All patients who attended at least one joint transition consultation between January 1, 2022 and January 31, 2026 and who met the study eligibility criteria were identified retrospectively from medical records and consultation reports. The study is based on routinely collected clinical data from this transition care pathway.
Who may be able to join
- Young adults with an acquired brain injury that occurred during childhood or adolescence;
- Who have attended at least one paediatric-to-adult rehabilitation transition consultation at the HPEVM between 1 January 2022 and 31 January 2026;
- For whom medical records and consultation reports are available.
Who cannot join
- Lack of usable medical records
- Patients not being monitored as part of the joint consultation
Trial locations and contacts
1 site in 1 country.
France1 site
Hôpitaux Paris Est Val-de-Marne - Unité de transition Enfants Adultes
Saint-Maurice, 94410
About this study
Official title: Characteristics and Vulnerabilities of Young Adults With Acquired Brain Injury During the Transition From Pediatric to Adult Care: A Four-Year Retrospective Analysis of Joint Physical and Rehabilitation Medicine Consultations
This retrospective, single-center observational study evaluates young adults with acquired brain injury who attended a joint pediatric-adult Physical and Rehabilitation Medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 2022 and January 2026. The study aims to describe their clinical, functional, neuropsychological, and psychosocial characteristics and to identify vulnerability factors potentially associated with disruption of follow-up during the transition to adult care. Data are retrospectively collected from medical records and consultation reports.
Read the detailed description
Transition from pediatric to adult healthcare represents a vulnerable period for adolescents and young adults with chronic conditions, particularly for individuals with acquired brain injury who may present persistent motor, cognitive, behavioral, neuropsychological, and psychosocial impairments.
This retrospective single-center study analyzes joint pediatric-adult Physical and Rehabilitation Medicine transition consultations performed at Hôpitaux Paris Est Val-de-Marne between January 1, 2022 and January 31, 2026.
The study population includes young adults over 18 years of age with acquired brain injury occurring during childhood or adolescence who attended at least one joint transition consultation and for whom medical records and consultation reports are available.
Retrospectively collected data include demographic characteristics, medical history, type of acquired brain injury, associated conditions, motor and cognitive impairments, neuropsychological findings, educational and professional status, autonomy, family support, living conditions, and medico-social orientation.
The primary objective is to describe the clinical, functional, neuropsychological, and psychosocial characteristics of this population at the time of transition to adult care. Secondary objectives include identifying vulnerability factors potentially associated with disruption of follow-up, describing specific needs during the transition period, and informing optimization of the current transition care model.
- Conditions
- Acquired Brain Injury
- Keywords
- acquired brain injury, transition to Adult Care, Physical and Rehabilitation Medicine, Continuity of care, young adults, Follow-up Discontinuation
- Medical subject headings
- Brain Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Young adults with acquired brain injury | Young adults aged over 18 years with acquired brain injury occuring during children or adolescence who attended at least one joint pediatric-adult physical dans rehabilitation medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 1, 2022 dans January 31, 2026. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants by Clinical and Functional Characteristic
Number of participants according to clinical and functional characteristics documented in medical records and transition consultation reports, including type of acquired brain injury, associated medical conditions, motor impairments, and cognitive or neuropsychological impairments.
Measured: Baseline (first joint pediatric-adult transition consultation)
Educational and employment status
Educational and employment characteristics, including level of education, school or university accommodations, and current employment status.
Measured: At the joint pediatric-adult transition consultation, retrospectively assessed from consultations performed between January 2022 and January 2026.
Number of Participants by Psychosocial and Environmental Characteristic
Number of participants according to psychosocial and environmental characteristics documented in medical records and transition consultation reports, including autonomy, family support, living conditions, lifestyle, and medico-social orientation.
Measured: aseline (first joint pediatric-adult transition consultation)
Secondary outcomes (1)
Number of Participants With Vulnerability Factors at Transition to Adult Care
Number of participants with documented vulnerability factors at transition to adult care, based on medical records and transition consultation reports. Factors may include cognitive or motor impairments, reduced autonomy, limited family support, adverse living conditions, and educational or employment difficulties.
Measured: Baseline (first joint pediatric-adult transition consultation)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Oct 2026
- Study start1 Jul 2026
- Primary completion1 Sep 2026
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acquired Brain InjuryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hopitaux de Saint-Maurice
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07881042
- Sponsor's protocol ID
- NEURO-TEA
- Acronym
- NEURO-TEA
- Status last verified
- Oct 2026
- First submitted
- 28 Sep 2026
- Last updated
- 19 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because this is a retrospective, single-center study based on routinely collected medical record data containing sensitive clinical and psychosocial information. The dataset is pseudonymized and access is restricted to authorized study personnel in accordance with applicable data protection requirements. Only aggregated, non-identifiable results will be reported in publications or presentations.
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Characteristics and Vulnerabilities of Young Adults With Acquired Brain Injury During the Transition From Pediatric to Adult Care: A Four-Year Retrospective Analysis of Joint Physical and Rehabilitation Medicine Consultations
- ClinicalTrials.gov ID
- NCT07881042
- Acronym / sponsor ID
- NEURO-TEA / NEURO-TEA
- Conditions
- Acquired Brain Injury
- Keywords
- acquired brain injury, transition to Adult Care, Physical and Rehabilitation Medicine, Continuity of care, young adults, Follow-up Discontinuation
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 72 participants (actual)
- Lead sponsor
- Hopitaux de Saint-MauriceUniversity, hospital or other
- Study start
- 1 Jul 2026 (actual)
- Primary completion
- 1 Sep 2026 (actual)
- Study completion
- Dec 2026 (estimated)
- First posted
- 19 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This retrospective, single-center observational study evaluates young adults with acquired brain injury who attended a joint pediatric-adult Physical and Rehabilitation Medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 2022 and January 2026. The study aims to describe their clinical, functional, neuropsychological, and psychosocial characteristics and to identify vulnerability factors potentially associated with disruption of follow-up during the transition to adult care. Data are retrospectively collected from medical records and consultation reports.
Detailed description
Transition from pediatric to adult healthcare represents a vulnerable period for adolescents and young adults with chronic conditions, particularly for individuals with acquired brain injury who may present persistent motor, cognitive, behavioral, neuropsychological, and psychosocial impairments.
This retrospective single-center study analyzes joint pediatric-adult Physical and Rehabilitation Medicine transition consultations performed at Hôpitaux Paris Est Val-de-Marne between January 1, 2022 and January 31, 2026.
The study population includes young adults over 18 years of age with acquired brain injury occurring during childhood or adolescence who attended at least one joint transition consultation and for whom medical records and consultation reports are available.
Retrospectively collected data include demographic characteristics, medical history, type of acquired brain injury, associated conditions, motor and cognitive impairments, neuropsychological findings, educational and professional status, autonomy, family support, living conditions, and medico-social orientation.
The primary objective is to describe the clinical, functional, neuropsychological, and psychosocial characteristics of this population at the time of transition to adult care. Secondary objectives include identifying vulnerability factors potentially associated with disruption of follow-up, describing specific needs during the transition period, and informing optimization of the current transition care model.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Young adults with acquired brain injury | – | –Young adults aged over 18 years with acquired brain injury occuring during children or adolescence who attended at least one joint pediatric-adult physical dans rehabilitation medicine transition consultation at Hôpitaux Paris Est Val-de-Marne between January 1, 2022 dans January 31, 2026. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of young adults with acquired brain injury occurring during childhood or adolescence who received care within the joint pediatric-adult Physical and Rehabilitation Medicine transition program at Hôpitaux Paris Est Val-de-Marne. All patients who attended at least one joint transition consultation between January 1, 2022 and January 31, 2026 and who met the study eligibility criteria were identified retrospectively from medical records and consultation reports. The study is based on routinely collected clinical data from this transition care pathway.
Key inclusion criteria (3 listed)
- Young adults with an acquired brain injury that occurred during childhood or adolescence;
- Who have attended at least one paediatric-to-adult rehabilitation transition consultation at the HPEVM between 1 January 2022 and 31 January 2026;
- For whom medical records and consultation reports are available.
Key exclusion criteria (2 listed)
- Lack of usable medical records
- Patients not being monitored as part of the joint consultation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of Participants by Clinical and Functional Characteristic
Time frame: Baseline (first joint pediatric-adult transition consultation)
Number of participants according to clinical and functional characteristics documented in medical records and transition consultation reports, including type of acquired brain injury, associated medical conditions, motor impairments, and cognitive or neuropsychological impairments.
Educational and employment status
Time frame: At the joint pediatric-adult transition consultation, retrospectively assessed from consultations performed between January 2022 and January 2026.
Educational and employment characteristics, including level of education, school or university accommodations, and current employment status.
Number of Participants by Psychosocial and Environmental Characteristic
Time frame: aseline (first joint pediatric-adult transition consultation)
Number of participants according to psychosocial and environmental characteristics documented in medical records and transition consultation reports, including autonomy, family support, living conditions, lifestyle, and medico-social orientation.
1 secondary outcome
Number of Participants With Vulnerability Factors at Transition to Adult Care
Time frame: Baseline (first joint pediatric-adult transition consultation)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because this is a retrospective, single-center study based on routinely collected medical record data containing sensitive clinical and psychosocial information. The dataset is pseudonymized and access is restricted to authorized study personnel in accordance with applicable data protection requirements. Only aggregated, non-identifiable results will be reported in publications or presentations.
Related trials for Acquired Brain Injury
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
Enrolling by invitationPhase 1
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Mild Traumatic Brain Injury
RecruitingObservational study
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
Moderate Traumatic Brain Injury
RecruitingPhase 2
Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder
Alcohol Use Disorder
Not yet recruitingPhase 1
Nanopulse Laser Therapy
TBI (Traumatic Brain Injury)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acquired Brain Injury, run by Hopitaux de Saint-Maurice at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Participants by Clinical and Functional Characteristic (time frame: Baseline (first joint pediatric-adult transition consultation)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026.